The MedStar Health—Georgetown/Washington Hospital Center Fellowship Program in Hematology and Oncology
This is a small but robust program that can be tailored to meet an individual fellow’s needs. As part of the safety-net hospital for Washington, D.C., the cancer center cares for the most new cancer diagnosis in the D.C. area.
We prioritize clinical training and autonomy in a socioeconomically diverse practice setting. Our excellent reputation sets our graduates apart when looking for permanent positions.
Why train here
We offer excellent clinical training in hematology and oncology during the first 2 years of your fellowship and thoroughly prepare you for both subspecialty board exams.
The majority of our fellows pursue academic careers.
We have clinical and research ties with Georgetown University Hospital, the National Institutes of Health (NIH), and the VA medical center. We have research ties with the Lombardi Cancer Center and Georgetown, the NIH, and the Food and Drug Administration (FDA).
The fellowship supports opportunities to do rotations at the Cancer Therapy Evaluation Program (CTEP) or the Food and Drug Administration (FDA). Community subspecialty rotations and rotations at the VA Medical Center can be arranged.
Fellows have opportunities to do research at any of our affiliated institutions. We also encourage fellows to participate in committees at the American Society of Hematology (ASH) or the American Society of Clinical Oncology (ASCO), both of which have headquarters in Washington, D.C.
We are pleased to inform you that the two Hematology/Oncology fellowship programs sponsored by the MedStar Health GME Consortium (the Georgetown University and Washington Hospital Center programs) have merged under the program ID# 1551012148. For the upcoming match, we will be entering a quota of six (6) fellows under the aforementioned program ID number.
This merger creates a larger program that optimizes clinical experiences and expands education and research opportunities. Both hospitals have large cancer centers with complementary experiences: MedStar Georgetown University Hospital has phase 1 trials, very active hematology malignancy groups (cellular therapy, leukemia, and lymphoma group), and offers subspecialty oncology care. Additionally, the relationship with Georgetown University School of Medicine provides teaching opportunities and faculty appointments for fellows. Combined research between Georgetown’s Lombardi Cancer Center and MedStar Health’s Research Institute offers a broad range of research opportunities from basic science labs, bench-top and clinical-translational research. MedStar Washington Hospital Center is a large urban hospital with a Level 1 trauma center, the region’s burn center, and a heart and vascular hub. The large cancer center provides a full range of oncology services. Fellows have significant exposure to sickle cell disease and complex coagulation issues. The patient population is extremely diverse, thus allowing for clinical exposure and learning ranging from “bread and butter” oncology experiences to the most complex patients. Significant opportunities to engage in all levels of research, from the bench to the bedside, in addition to a focus on research in racial disparities. After the first eighteen months of clinical experiences, fellows have the option to choose from unique training tracks that align with clinical practice and research goals.
We are excited about the integration of these two programs as it will lead to a stronger fellowship program. The combined faculty is unparalleled in terms of expertise and diversity. We look forward to discussing this further on interview day. Our website information is not yet updated but we anticipate this will occur mid-late September.
Interested in applying?